SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-223656
Filing Date
2021-07-26
Accepted
2021-07-26 07:35:33
Documents
16
Period of Report
2021-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d182412d8k.htm   iXBRL 8-K 31108
2 EX-10.1 d182412dex101.htm EX-10.1 61331
3 EX-99.1 d182412dex991.htm EX-99.1 11849
7 GRAPHIC g182412g0723234411765.jpg GRAPHIC 2369
8 GRAPHIC g182412g0723234755534.jpg GRAPHIC 2384
  Complete submission text file 0001193125-21-223656.txt   261998

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20210726.xsd EX-101.SCH 2912
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20210726_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20210726_pre.xml EX-101.PRE 10966
9 EXTRACTED XBRL INSTANCE DOCUMENT d182412d8k_htm.xml XML 3275
Mailing Address 6200 LOOKOUT RD. BOULDER CO 80301
Business Address 6200 LOOKOUT RD. BOULDER CO 80301 720.643.5200
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 211112378
SIC: 8071 Services-Medical Laboratories